Alden K J, Motew S J, Sharma A C, Ferguson J L
Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 60612-7342, USA.
Shock. 1998 Apr;9(4):289-95. doi: 10.1097/00024382-199804000-00009.
We hypothesized that plasma nitric oxide (NO), generated via inducible NO synthase (iNOS) or endothelial constitutive NO synthase and measured via its by-products NO2- and NO3- (NO2- + NO3- = NOx) would increase and remain elevated during chronic peritoneal sepsis. We further hypothesized that treatment with aminoguanidine (AG; 50 mg/kg), a selective iNOS inhibitor, would decrease NO production and alter blood flow. Sprague Dawley rats were randomized to septic and nonseptic groups. Septic rats received an intraperitoneal cecal slurry (200 mg of cecal material/5 mL 5% dextrose-H2O/kg); control rats received sterile 5% dextrose-H2O (5 mL/kg) only. Plasma NOx and hemodynamics were measured 0, 4, 12, 24, and 48 h after sepsis or sham induction. We also examined the effect of AG, an iNOS inhibitor, on plasma NOx levels and tissue blood flow at 24 h. Septic rats uniformly displayed signs of sepsis, including lethargy, piloerection, and diarrhea. NOx levels were significantly elevated compared with controls at 4, 12, 24, and 48 h (p < or = .05). Septic rats also demonstrated hypotension (t = 12, 24, and 48 h) and tachycardia (t = 4, 12, 24, and 48 h). The infusion of AG (50 mg/kg intravenously for 30 min) at 24 h significantly decreased plasma NOx in septic animals. Plasma NOx concentrations returned to basal levels by 90 min after infusion of AG. In addition, blood flow studies demonstrated that AG treatment in nonseptic rats resulted in a significant decrease in blood flow to the stomach, skin, and adipose tissue, whereas AG infusion did not significantly alter the regional perfusion profile in septic animals. Furthermore, treatment with AG did not significantly alter mean arterial pressure in either group; however, nonseptic animals exhibited a decrease in stroke volume, and septic animals demonstrated an increase in heart rate. In contrast to the rise and fall of NOx levels in endotoxemia, this study demonstrates that the initial rise is sustained during 48 h of peritoneal sepsis. This sustained increase in NOx levels in this model correlated with the observable signs of systemic infection and may relate to enhanced iNOS activity. AG infusion demonstrated variable effects on regional tissue blood flow profiles in septic and nonseptic animals and attenuated the increase in plasma NOx levels in septic animals, an index of iNOS activity.
我们假设,通过诱导型一氧化氮合酶(iNOS)或内皮型组成型一氧化氮合酶产生并通过其副产物亚硝酸根离子(NO2-)和硝酸根离子(NO3-)(NO2- + NO3- = NOx)测定的血浆一氧化氮(NO)在慢性腹膜败血症期间会增加并持续升高。我们进一步假设,用选择性iNOS抑制剂氨基胍(AG;50 mg/kg)治疗会减少NO的产生并改变血流。将Sprague Dawley大鼠随机分为败血症组和非败血症组。败血症大鼠接受腹腔内盲肠匀浆(200 mg盲肠物质/5 mL 5%葡萄糖 - 水/kg);对照大鼠仅接受无菌5%葡萄糖 - 水(5 mL/kg)。在败血症或假手术诱导后0、4、12、24和48小时测量血浆NOx和血流动力学。我们还在24小时时研究了iNOS抑制剂AG对血浆NOx水平和组织血流的影响。败血症大鼠均表现出败血症的体征,包括嗜睡、竖毛和腹泻。与对照组相比,在4、12、24和48小时时NOx水平显著升高(p≤0.05)。败血症大鼠还表现出低血压(在12、24和48小时)和心动过速(在4、12、24和48小时)。在24小时时静脉内输注AG(50 mg/kg,持续30分钟)可显著降低败血症动物的血浆NOx。输注AG后90分钟,血浆NOx浓度恢复到基础水平。此外,血流研究表明,AG治疗使非败血症大鼠的胃、皮肤和脂肪组织血流显著减少,而AG输注并未显著改变败血症动物的局部灌注情况。此外,AG治疗在两组中均未显著改变平均动脉压;然而,非败血症动物的每搏输出量减少,败血症动物的心率增加。与内毒素血症中NOx水平的先升高后降低不同,本研究表明,在腹膜败血症的48小时内,最初的升高持续存在。该模型中NOx水平的持续升高与全身感染的可观察体征相关,可能与iNOS活性增强有关。AG输注对败血症和非败血症动物的局部组织血流情况产生了不同影响,并减弱了败血症动物血浆NOx水平的升高,血浆NOx水平是iNOS活性的一个指标。